Skip to main content
. 2016 Oct 8;160(2):313–322. doi: 10.1007/s10549-016-4007-5

Table 2.

Outcome for patients with ER positive tumors divided by PgR (IHC) status

Tam vs. control PgR (IHC) Number of patients/events HR (95 % CI) p value P for interaction
TAM Control
Recurrence rate All 329/70 289/102 0.54 (0.40–0.74) <0.001 0.03
≥10 % 225/43 182/72 0.43 (0.29–0.62) <0.001
<10 % 104/27 107/30 0.87 (0.52–1.46) 0.59
Distant recurrence rate All 329/51 289/79 0.54 (0.38–0.76) 0.001 0.17
≥10 % 225/31 182/53 0.45 (0.29–0.70) <0.001
<10 % 104/20 107/26 0.75 (0.42–1.34) 0.33
Breast cancer specific mortality rate All 329/43 289/72 0.51 (0.35–0.74) <0.001 0.33
≥10 % 225/26 182/47 0.44 (0.27–0.71) 0.001
<10 % 104/17 107/25 0.65 (0.35–1.21) 0.17